查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405758

qPCR 設備市場規模、佔有率、趨勢分析報告：按測試類型、地區、細分市場預測，2023-2030 年

qPCR Instruments Market Size, Share & Trends Analysis Report By Test Type (7500, QuantStudio Dx, QuantStudio 5, ViiA 7 Dx, One Step/One Step Plus, LightCycler 2.0, Cobas 4800, CFX96, SmartCycler), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 109 Pages | 商品交期: 2-10個工作天內

價格

qPCR設備市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，到2030年，全球qPCR設備市場規模預計將達到16.4億美元。

預計2023年至2030年複合年成長率為7.0%。該市場是由新穎和先進產品的推出以及對高效診斷設備不斷成長的需求所推動的。

全球 SARS-CoV-2 感染發病率迅速上升，推動了對 qPCR 設備和用品的需求。發病率上升預計會增加預防性篩檢的數量。這是因為各國無法在不進行篩檢的情況下確定 COVID-19 患者的數量。

三種基本分子檢測的小型化有望提高診斷結果的準確性和特異性，從而增加對分子診斷產品的需求。這些改進預計將使 POC 分子診斷測試更容易獲得，並提供更快、更有效的測試結果。例如，Biomolecular Systems 的 Mic qPCR 系統重量僅為 2 公斤，非常攜帶且易於操作。

QuantStudio 5 Dx 即時 PCR 系統等新推出的產品為消費者提供了改進的工作流程和大容量測試，以更快地提供結果。成本效益和簡化的軟體提供了更多優勢。此外，該設備在 50 多個國家獲得核准也促進了市場成長。該設備還配備了伴同性診斷研究的功能，提高了其競爭力。

由於存在高度先進且更準確的數位 PCR 設備，該市場面臨外部替代品的高度威脅。由於市場上有大量產品，內部替代品的威脅很大。然而，由於這些設備的價格較高，整體威脅預計將減少並保持在中等水平。

COVID-19 增加了診斷設備的機會。然而，先進的 PCR 技術（如 dPCR）在新興經濟體中更受青睞，因為它們有助於降低假陽性率。研究開發高效 qPCR 設備可以減少設備替代品的威脅並促進市場成長。

近年來，PCR在靈敏度、準確性、效率和成本效益方面取得了技術進步。主要企業正在引入新技術以保持競爭力。

qPCR 設備市場報告亮點

  • GeneXpert 細分市場在 2022 年佔據最大的銷售佔有率，為 21.67%。這是由於 SARS-CoV-2 大流行期間感染檢測的採用率提高。
  • Rotor-Gene Q 5Plex HRM 系統可在短短 90 分鐘內產生結果，比許多其他 qPCR 儀器更快。
  • 北美主導全球qPCR設備市場，2022年佔最大銷售佔有率，達42.73%。該地區的成長得益於監管支持的增加和新產品發布的增加。
  • 預計亞太地區在預測期內將以 8.9% 的最快複合年成長率成長。未滿足的醫療需求中的開拓機會、不斷增加的科學研究舉措以及積極的經濟成長是該市場的主要成長動力。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 qPCR 設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • qPCR設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 qPCR 設備：測試類型的估計和趨勢分析

  • qPCR 設備市場：重點
  • qPCR 儀器市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 7500
  • Quant Studio Dx
  • Quant Studio 5
  • ViiA 7 Dx
  • One Step/One Step Plus
  • LightCycler 2.0
  • Cobas 4800
  • CFX96
  • SmartCycler
  • GeneXpert
  • Rotor-Gene Q 5Plex HRM System
  • Rotor-Gene Q
  • BIOFIRE FILMARRAY System
  • BMS Mic System

第5章 qPCR 設備市場：區域估計與趨勢分析

  • 區域展望
  • qPCR 儀器市場（按地區）：重點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • QIAGEN
    • Agilent Technologies, Inc.
    • Abbott
    • BIOMERIEUX
    • Quantabio
    • Azure Biosystems Inc.
    • Bio Molecular Systems
Product Code: GVR-4-68038-339-3

qPCR Instruments Market Growth & Trends:

The global qPCR instruments market size is expected to reach USD 1.64 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.0% from 2023 to 2030. The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is being driven by the spike in the incidence of SARS-CoV-2 infections globally. The rise in the incidence is expected to add to the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

The miniaturization of three basic molecular assays is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic tests to yield quick and effective test results. For instance, the Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the device highly portable and easy to handle.

Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages. Furthermore, the approval of the instrument in over 50 countries can help strengthen the market growth. The instrument is also equipped with measures for research companion diagnostics, giving it a competitive edge.

The market has a high threat of external substitutes owing to the presence of digital PCR instruments that are highly advanced and more accurate. The strong threat of internal substitution can be attributed to the presence of numerous products available in the market. However, the higher price of these instruments is anticipated to reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are preferred more in developed economies as they can help reduce false-positive rates. The research on developing efficient qPCR instruments can reduce the threat of substitution of devices and improve market growth.

Over recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key players are introducing novel technologies to maintain a competitive edge.

qPCR Instruments Market Report Highlights:

  • The GeneXpert segment accounted for the largest revenue share of 21.67% in 2022. This is attributed to its increased adoption rate during the SARS-CoV-2 pandemic to detect infections.
  • The Rotor-Gene Q 5Plex HRM System segment is expected to grow at the fastest CAGR of 8.8% during the forecast period owing to the factors such as Rotor-Gene Q 5Plex HRM System can deliver results in as little as 90 minutes, which is faster than many other qPCR instruments.
  • North America dominated the global qPCR instruments market and accounted for the largest revenue share of 42.73% in 2022. The growth of this region is attributed to the growing regulatory support and increasing launches of novel products.
  • Asia Pacific is expected to grow at the fastest CAGR of 8.9% over the forecast period. The major untapped opportunities in the form of unmet medical needs, increasing initiatives for scientific research, and positive economic growth are primary growth drivers of this market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. qPCR Instruments Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. qPCR Instruments Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. qPCR Instruments: Test Type Estimates & Trend Analysis

  • 4.1. qPCR Instruments Market: Key Takeaways
  • 4.2. qPCR Instruments Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. 7500
    • 4.3.1. 7500 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. QuantStudio Dx
    • 4.4.1. Quant Studio Dx market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. QuantStudio 5
    • 4.5.1. Quant Studio 5 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. ViiA 7 Dx
    • 4.6.1. ViiA 7 Dx market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. One Step/One Step Plus
    • 4.7.1. One Step/One Step Plus market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. LightCycler 2.0
    • 4.8.1. Light Cycler 2.0 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Cobas 4800
    • 4.9.1. Cobas 4800 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. CFX96
    • 4.10.1. CFX96 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. SmartCycler
    • 4.11.1. Smart Cycler market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. GeneXpert
    • 4.12.1. GeneXpert market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. Rotor-Gene Q 5Plex HRM System
    • 4.13.1. Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. Rotor-Gene Q
    • 4.14.1. Rotor-Gene Q market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. BIOFIRE FILMARRAY System
    • 4.15.1. BIOFIRE FILMARRAY Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. BMS Mic System
    • 4.16.1. BMS Mic System market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. qPCR Instruments Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. qPCR Instruments Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Regulatory Framework/Reimbursement Structure
      • 5.3.2.3. Competitive Scenario
      • 5.3.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Regulatory Framework/Reimbursement Structure
      • 5.3.3.3. Competitive Scenario
      • 5.3.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Denmark
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Thermo Fisher Scientific, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. F. Hoffmann-La Roche Ltd.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Bio-Rad Laboratories, Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Danaher
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. QIAGEN
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Agilent Technologies, Inc.
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Abbott
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. BIOMERIEUX
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Quantabio
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Azure Biosystems Inc.
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Bio Molecular Systems
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 5 Canada qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 6 Europe qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 7 Europe qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 9 UK qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 10 France qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 11 Italy qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 12 Spain qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Denmark qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 14 Sweden qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 15 Norway qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 19 China qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 20 India qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 21 Australia qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Thailand qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 23 South Korea qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 24 Latin America qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 25 Latin America qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 27 Mexico qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 28 Argentina qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 33 UAE qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait qpcr instruments market, by test type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 qPCR instruments: Market outlook
  • Fig. 8 qPCR instruments: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 qPCR instruments market driver impact
  • Fig. 13 qPCR instruments market restraint impact
  • Fig. 14 qPCR instruments market strategic initiatives analysis
  • Fig. 15 qPCR instruments market: Test Type movement analysis
  • Fig. 16 qPCR instruments market: Test Type outlook and key takeaways
  • Fig. 17 7500 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 QuantStudio Dx market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 QuantStudio 5 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 ViiA 7 Dx market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 One Step/One Step Plus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 LightCycler 2.0 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Cobas 4800 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 CFX96 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 SmartCycler market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 GeneXpert market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Rotor-Gene Q market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 BIOFIRE FILMARRAY SYSTEMS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 BMS Mic System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global qPCR instruments market: Regional movement analysis
  • Fig. 32 Global qPCR instruments market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)